We initiated the present study to identify new genes associated with colorectal cancer. In a previously published microarray study an EST (W80763), later identified as the gene hFKBP10 (NM_021939), was found to be strongly expressed in tumors while absent in the normal mucosa. Here we describe this gene hFKBP10 together with its encoded protein hFKBP65 as a novel marker associated with colorectal cancer. Analysis of 31 colorectal adenocarcinomas and 14 normal colorectal mucosa by RealTime PCR for hFKBP10 showed a significant up-regulation in tumors, when compared with normal mucosa. Immunohistochemical analysis of 26 adenocarcinomas and matching normal mucosa, as well as benign hyperplastic polyps and adenomas, using a monoclonal antihFKBP65 antibody, showed that the protein was not present in normal colorectal epithelial cells, but strongly expressed in the tumor cells of colorectal cancer. The protein was also expressed in fibroblasts of both normal mucosa and tumor tissue. Western blot analysis of matched tumors and normal mucosa supported the finding of increased hFKBP65 expression in tumors compared with normal mucosa, in addition to identifying the molecular mass of hFKBP65 to ϳ72 kDa. Cellular localization and glycosylation studies revealed the hFKBP65 protein to be localized in the endoplasmic reticulum, and to be N-glycosylated. In conclusion, the protein hFKBP65 is associated with colorectal cancer, and we hypothesize the protein to be involved in fibroblast and transformed epithelial cell-specific protein synthesis in the endoplasmic reticulum. Molecular & Cellular Proteomics 4:534 -544, 2005.Despite progresses made during the last decades, sporadic colorectal cancer remains one of the most frequent neoplasias in the Western world. Approximately 50% of patients diagnosed with colorectal cancer die within 5 years from diagnosis (1); however, an early diagnosis will improve the patients' chance of survival dramatically. Multiple genetic alterations are necessary to develop colorectal cancer (2), but very few colorectal cancers have gone through the exact same series of alterations. Furthermore, recent studies have shown a differential gene expression between the proximal and the distal colon (3, 4), which means that the localization of a tumor within the colon also has to be taken into account when investigating this disease. Altogether, new models based on a deeper molecular understanding of the disease are required to improve screening, diagnosis, treatment, and, ultimately, survival.In a previous study (5), we identified a subset of genes and ESTs up-or down-regulated in the four different stages of colorectal cancer (Dukes stages A, B, C, and D) as compared with normal colorectal mucosa (N). The expression of especially one EST (W80763), later identified as the gene hFKBP10 (NM_021939), seemed to be a potentially good marker for colorectal cancer. The gene was not expressed in normal colorectal mucosa and highly expressed in all four Dukes stages. hFKBP10 is a member of the large gene family of immu...